Citigroup’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-106
| Closed | -$823 | – | 6321 |
|
|
2025
Q3 | $823 | Sell |
106
-2,814
| -96% | -$21.1K | ﹤0.01% | 5656 |
|
|
2025
Q2 | $21.6K | Sell |
2,920
-345
| -11% | -$3.03K | ﹤0.01% | 5056 |
|
|
2025
Q1 | $28.1K | Sell |
3,265
-648
| -17% | -$10K | ﹤0.01% | 5020 |
|
|
2024
Q4 | $140K | Buy |
3,913
+621
| +19% | +$32.1K | ﹤0.01% | 4649 |
|
|
2024
Q3 | $156K | Buy |
3,292
+2,269
| +222% | +$100K | ﹤0.01% | 4526 |
|
|
2024
Q2 | $51.4K | Sell |
1,023
-15,571
| -94% | -$1.13M | ﹤0.01% | 4564 |
|
|
2024
Q1 | $1.86M | Buy |
16,594
+15,955
| +2,497% | +$1.59M | ﹤0.01% | 2491 |
|
|
2023
Q4 | $37.1K | Buy |
639
+570
| +826% | +$22.9K | ﹤0.01% | 4676 |
|
|
2023
Q3 | $2.2K | Sell |
69
-4,956
| -99% | -$236K | ﹤0.01% | 4937 |
|
|
2023
Q2 | $413K | Sell |
5,025
-11,746
| -70% | -$1.72M | ﹤0.01% | 3506 |
|
|
2023
Q1 | $1.72M | Buy |
16,771
+9,032
| +117% | +$1.27M | ﹤0.01% | 2119 |
|
|
2022
Q4 | $1.13M | Sell |
7,739
-152
| -2% | -$25.7K | ﹤0.01% | 2501 |
|
|
2022
Q3 | $1.33M | Buy |
7,891
+7,507
| +1,955% | +$1.22M | ﹤0.01% | 2482 |
|
|
2022
Q2 | $44K | Buy |
384
+130
| +51% | +$12.2K | ﹤0.01% | 4594 |
|
|
2022
Q1 | $25K | Sell |
254
-8,827
| -97% | -$1.03M | ﹤0.01% | 5037 |
|
|
2021
Q4 | $1.41M | Buy |
9,081
+4,547
| +100% | +$885K | ﹤0.01% | 2911 |
|
|
2021
Q3 | $1.07M | Sell |
4,534
-2,885
| -39% | -$843K | ﹤0.01% | 3033 |
|
|
2021
Q2 | $2.52M | Sell |
7,419
-1,785
| -19% | -$676K | ﹤0.01% | 2482 |
|
|
2021
Q1 | $3.72M | Buy |
9,204
+8,675
| +1,640% | +$4.21M | ﹤0.01% | 2020 |
|
|
2020
Q4 | $352K | Buy |
529
+375
| +244% | +$209K | ﹤0.01% | 4518 |
|
|
2020
Q3 | $72K | Sell |
154
-890
| -85% | -$450K | ﹤0.01% | 5344 |
|
|
2020
Q2 | $611K | Buy |
1,044
+638
| +157% | +$218K | ﹤0.01% | 4053 |
|
|
2020
Q1 | $59K | Buy |
406
+118
| +41% | +$20.6K | ﹤0.01% | 5831 |
|
|
2019
Q4 | $41K | Buy |
288
+195
| +210% | +$14.3K | ﹤0.01% | 6466 |
|
|
2019
Q3 | $4K | Sell |
93
-274
| -75% | -$19.9K | ﹤0.01% | 7394 |
|
|
2019
Q2 | $37K | Buy |
367
+231
| +170% | +$27.2K | ﹤0.01% | 6724 |
|
|
2019
Q1 | $17K | Buy |
136
+4
| +3% | +$503 | ﹤0.01% | 7035 |
|
|
2018
Q4 | $14K | Buy |
132
+19
| +17% | +$3.01K | ﹤0.01% | 7036 |
|
|
2018
Q3 | $28K | Buy |
+113
| New | +$37.9K | ﹤0.01% | 6920 |
|
|
2018
Q2 | – | Sell |
-2
| Closed | -$1K | – | 7686 |
|
|
2018
Q1 | $1K | Sell |
2
-51
| -96% | -$20.1K | ﹤0.01% | 7455 |
|
|
2017
Q4 | $21K | Sell |
53
-699
| -93% | -$305K | ﹤0.01% | 6711 |
|
|
2017
Q3 | $325K | Buy |
+752
| New | +$296K | ﹤0.01% | 4550 |
|
Other funds holding MRSN
NI
BCLSI
RSCM
AV
AAA
